FindTrial
Sign In

Registry Study on the Integration of Traditional Chinese and Western Medicine in the Treatment of Systemic Lupus Erythematosus.

Registry Study on the Integration of Traditional Chinese and Western Medicine in the Treatment of Systemic Lupus Erythematosus.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002394
Enrollment
Unknown
Registered
2025-12-06
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus (SLE)

Interventions

Observed Population:None

Sponsors

The Second Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Classification criteria published by SLICC in 2012 or the SLE classification criteria jointly released by EULAR/ACR in 2019; (2) Participants aged between 18 and 75 years; (3) Patients who are informed and consent to participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with schizophrenia or other mental disorders who are unable to fully recognize their own actions; (2) Individuals with poor adherence or low cooperation in questionnaire surveys; (3) Individuals currently or planning to participate in other interventional clinical trials for systemic lupus erythematosus (SLE).

Design outcomes

Primary

MeasureTime frame
Lupus Disease Activity Index;—

Secondary

MeasureTime frame
Traditional Chinese Medicine Symptom Scoring;Organ Damage Index;Quality of Life Assessment;Hormone dosage;Infection Incidence Rate;Recurrence rate;—

Countries

China

Contacts

Public ContactWang Xinchang

The Second Affiliated Hospital of Zhejiang Chinese Medical University

ossani@126.com057185868248

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026